STARLA ALLEN: Open Payments
NPI 1992071179 · FAIRFAX, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,332 in 126 payments from 21 companies in 2025. Trend: 2023 $1,644 · 2024 $2,242 · 2025 $2,332
Food & beverage: $2,332
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $457 |
| Lilly USA, LLC | 12 | $298 |
| PFIZER INC. | 13 | $227 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $206 |
| Aimmune Therapeutics, Inc. | 10 | $194 |
| ABBVIE INC. | 15 | $174 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $151 |
| Novo Nordisk Inc | 6 | $120 |
| Exact Sciences Corporation | 5 | $84 |
| Medtronic, Inc. | 1 | $64 |
Products named: Kerendia, NURTEC ODT, AIRSUPRA, ZENPEP, JARDIANCE, MOUNJARO, BREZTRI, ZEPBOUND.
Industry payments across OK — which companies pay providers there.
